Kantor Neurology, 31 May 2022 Background Studies link c-Abl activation with the accumulation of pathogenic α-synuclein (αS) and neurodegeneration in Parkinson…
Kantor Neurology, 30 May 2022 #pascongress: Poster on Pfizer #Bosutinib #Bosulif, another tyrosine kinase inhibitor studied in Georgetown University phase 2…